|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Centers for Disease Control and Prevention Medentech Ltd. Emory University Center for Global Safe Water NewEnergy University for Development Studies, Tamale, Ghana |
| Information provided by: | Centers for Disease Control and Prevention |
| ClinicalTrials.gov Identifier: | NCT00252928 |
Purpose
The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.
| Condition | Intervention |
|
Diarrhea |
Other: Sodium dichloroisocyanurate (NaDCC) tablets Other: Placebo |
| MedlinePlus related topics: | Diarrhea Drinking Water |
| ChemIDplus related topics: | Sodium dichloroisocyanurate Dichloroisocyanuric acid |
| Study Type: | Interventional |
| Study Design: | Prevention, Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Factorial Assignment, Efficacy Study |
| Official Title: | Health Impact Study of a Water Treatment Tablet, Aquatabs, in Tamale, Ghana |
| Enrollment: | 240 |
| Study Start Date: | July 2006 |
| Study Completion Date: | November 2006 |
| Arms | Assigned Interventions |
|
A: Placebo Comparator
Placebo group does not receive Aquatabs.
|
Other: Placebo
Placebo
|
|
B: Experimental
Intervention arms receives Aquatabs.
|
Other: Sodium dichloroisocyanurate (NaDCC) tablets
Intervention arm receives NaDCC tablets to use for to disinfect their household water for use for 20L of water. Ideally, disinfection occurs every day.
|
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
-
Contacts and Locations| United States, Georgia | |||||
| Emory University Center for Global Safe Water | |||||
| Atlanta, Georgia, United States, 30322 | |||||
| Ghana | |||||
| NewEnergy | |||||
| Tamale, Ghana | |||||
| University of Development Studies | |||||
| Tamale, Ghana | |||||
| Centers for Disease Control and Prevention |
| Medentech Ltd. |
| Emory University Center for Global Safe Water |
| NewEnergy |
| University for Development Studies, Tamale, Ghana |
| Principal Investigator: | Seema Jain, MD | Centers for Disease Control and Prevention |
| Principal Investigator: | Robert Quick, MD | Centers for Disease Control and Prevention |
More Information
| Study ID Numbers: | CDC-NCID-4730 |
| First Received: | November 10, 2005 |
| Last Updated: | October 29, 2007 |
| ClinicalTrials.gov Identifier: | NCT00252928 |
| Health Authority: | United States: Federal Government; Ghana: University for Development Studies |
|
|
|
|